|
Volumn 35, Issue 5, 2013, Pages S1-S3
|
Abnormal Uterine Bleeding in Pre-Menopausal Women
a a a a a a a a a a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIFIBRINOLYTIC AGENT;
DANAZOL;
ESTROGEN;
GONADORELIN AGONIST;
LEVONORGESTREL;
MEDROXYPROGESTERONE ACETATE;
NONSTEROID ANTIINFLAMMATORY AGENT;
ORAL CONTRACEPTIVE AGENT;
TRANEXAMIC ACID;
ABNORMAL UTERINE BLEEDING;
ANAMNESIS;
ANEMIA;
ARTICLE;
BLOOD CELL COUNT;
BLOOD CLOTTING DISORDER;
BLOOD TRANSFUSION;
CANADA;
CONSENSUS DEVELOPMENT;
CONTROLLED STUDY;
DRUG MEGADOSE;
ECONOMIC ASPECT;
ENDOMETRIUM BIOPSY;
ENDOMETRIUM CANCER;
FAMILY HISTORY;
HUMAN;
HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM;
HYSTEROGRAPHY;
HYSTEROSCOPY;
IMMATURITY;
INTERVENTION STUDY;
MEDICAL PRACTICE;
MENARCHE;
METRORRHAGIA;
MYOMECTOMY;
OVARY INSUFFICIENCY;
PERSONAL EXPERIENCE;
PHYSICAL EXAMINATION;
PRACTICE GUIDELINE;
PREGNANCY;
PREGNANCY TEST;
PREMENOPAUSE;
QUALITY OF LIFE;
SOCIAL ASPECT;
SYSTEMATIC REVIEW;
THYROID DISEASE;
THYROID FUNCTION TEST;
TRANSVAGINAL ECHOGRAPHY;
UTERUS MYOMA;
VON WILLEBRAND DISEASE;
|
EID: 84975770584
PISSN: 17012163
EISSN: None
Source Type: Journal
DOI: 10.1016/S1701-2163(15)30732-5 Document Type: Article |
Times cited : (38)
|
References (0)
|